Adrenocorticotropic Hormone (ACTH): Definition and Function
Adrenocorticotropic hormone (ACTH) is a peptide hormone produced by the pituitary gland that plays a pivotal role in regulating adrenal gland function, particularly the production of glucocorticoids such as cortisol.
Key Characteristics of ACTH
- ACTH is the primary regulator of adrenal glucocorticoid production, making it a critical component of the hypothalamo-pituitary-adrenal axis 1
- ACTH is produced from proopiomelanocortin (POMC) in the anterior pituitary gland 1
- Normal ACTH levels are typically >5 pg/mL, with levels >29 pg/mL having 70% sensitivity and 100% specificity for diagnosing Cushing's disease (pituitary source of ACTH) 2
Physiological Functions
- ACTH stimulates steroidogenesis and steroid secretion from the adrenal cortex 1
- ACTH has differential acute vs chronic effects on aldosterone and glucocorticoid secretion 1
- ACTH influences adrenal growth, acting as both a mitogenic and differentiating factor 1
- ACTH activates multiple signaling cascades beyond the classical cyclic adenosine monophosphate (cAMP) pathway 1
Clinical Significance
Diagnostic Applications
- ACTH levels are used to determine whether Cushing's syndrome is ACTH-dependent or ACTH-independent 3
- Elevated ACTH levels indicate ACTH-dependent Cushing's syndrome (pituitary adenoma or ectopic source) 3
- Low or undetectable ACTH levels indicate ACTH-independent Cushing's syndrome (adrenal source) 3
ACTH Testing
- The high-dose (250-μg) ACTH stimulation test is recommended over the low-dose (1-μg) test for diagnosing critical illness-related corticosteroid insufficiency (CIRCI) 4
- The 250-μg ACTH stimulation test is preferred over evaluating hemodynamic response to hydrocortisone for diagnosing CIRCI 4
Pathological Conditions
- Genetic defects in the ACTH receptor (melanocortin 2 receptor) can cause familial glucocorticoid deficiency 5
- Overexpression of the ACTH receptor can lead to adrenal adenomas or hyperplasia associated with Cushing syndrome 5
- Isolated ACTH deficiency can occur as an immune-related adverse event following immune checkpoint inhibitor therapy 6
Management of ACTH-Related Disorders
- For primary adrenal insufficiency (high ACTH, low cortisol), replacement therapy with prednisone (5–10 mg daily) or hydrocortisone (10–20 mg orally every morning, 5–10 mg orally in early afternoon) is recommended 4
- Patients with adrenal insufficiency may require fludrocortisone (0.1 mg/d) for mineralocorticoid replacement 4
- For severe symptoms of adrenal insufficiency, IV stress-dose corticosteroids (hydrocortisone 100 mg or dexamethasone 4 mg) and normal saline (at least 2 L) are recommended 4
Emerging Therapeutic Approaches
- Novel long-acting monoclonal antibodies to ACTH (such as ALD1613) are being developed to control ACTH-driven pharmacology in conditions with elevated ACTH levels 7
- These antibodies can neutralize ACTH-induced signaling and reduce plasma corticosterone/cortisol levels 7
Important Clinical Considerations
- Primary and secondary adrenal insufficiency can be distinguished by the relationship between ACTH and cortisol 4
- All patients with adrenal insufficiency need education on stress dosing and a medical alert bracelet 4
- Endocrine consultation is recommended prior to surgery or any procedure for stress-dose planning 4